TSC2 and chronic myelogenous leukemia, BCR-ABL1 positive: Accordingly, loss of TSC2 diminished the effect of SHIN1 on mTORC1 signalling and differentiation in CML cells (Fig. 4g, h and Supplementary Fig. 5i, j).